chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Concussion, Feeling hot, Head injury, Syncope, Vision blurred
Clinical narrative: Received first Covid 19 vaccine and was told to walk around by person who administered injection since they did not have enough chairs.  Approximately five minutes after injection I was standing in an aisle when my vision became blurry and I felt a wave of heat come over my body.  I began to crouch down and passed out hitting my head causing a concussion.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: She got her vaccine, initially coughing, itching which was followed by wheezing, tightness in her chest, numbing throat.  There were paramedics on site who heard the wheezing in her chest, and she requested to be transported to the hospital.  In the ambulance her VS apparently changed at which point she felt her throat closing, and was given epinephrine and transported to the ER and given more epinephrine and stabilized.  Then admitted to the ICU and spent the night in the step-down unit and then discharged the following day on 3/31/2021.  Since getting out of the hospital she has not had any other reactions, and has been advised by multiple doctors to not receive the 2nd vaccine. She was taken to a facility.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Cough, Intensive care, Pharyngeal hypoaesthesia, Pruritus
Clinical narrative: She got her vaccine, initially coughing, itching which was followed by wheezing, tightness in her chest, numbing throat.  There were paramedics on site who heard the wheezing in her chest, and she requested to be transported to the hospital.  In the ambulance her VS apparently changed at which point she felt her throat closing, and was given epinephrine and transported to the ER and given more epinephrine and stabilized.  Then admitted to the ICU and spent the night in the step-down unit and then discharged the following day on 3/31/2021.  Since getting out of the hospital she has not had any other reactions, and has been advised by multiple doctors to not receive the 2nd vaccine. She was taken to a facility.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness, Wheezing
Clinical narrative: She got her vaccine, initially coughing, itching which was followed by wheezing, tightness in her chest, numbing throat.  There were paramedics on site who heard the wheezing in her chest, and she requested to be transported to the hospital.  In the ambulance her VS apparently changed at which point she felt her throat closing, and was given epinephrine and transported to the ER and given more epinephrine and stabilized.  Then admitted to the ICU and spent the night in the step-down unit and then discharged the following day on 3/31/2021.  Since getting out of the hospital she has not had any other reactions, and has been advised by multiple doctors to not receive the 2nd vaccine. She was taken to a facility.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood albumin decreased, Blood creatine phosphokinase MB, Blood creatine phosphokinase increased, Blood lactic acid, Blood magnesium normal
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood sodium decreased, Blood urea nitrogen/creatinine ratio, Brain natriuretic peptide increased, Cardiac failure congestive, Drug screen negative
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Haematocrit decreased, Haemoglobin decreased, Headache, Hepatic enzyme abnormal
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immature granulocyte percentage increased, Insomnia, International normalised ratio increased, Lymphocyte percentage decreased, Metabolic function test normal
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Nausea, Neutrophil percentage increased, Pain, Peripheral swelling
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Protein urine present, Prothrombin level normal, Red blood cell count decreased, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis normal, Vomiting, Walking aid user
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Anticoagulant therapy, Catheterisation cardiac abnormal, Chest pain, Coronary artery disease
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Left atrial dilatation, Left ventricular dysfunction
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Left ventricular enlargement, Left ventricular failure, Mitral valve incompetence, Myocardial infarction, Nausea
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Tricuspid valve incompetence, Troponin increased, Vomiting
Clinical narrative: 70YM w chest pain, lower extremity swelling, left arm pain and dyspnea started on 3/27, 2 days after Covid vaccine given on 3/25.  Presented to Hospital on 4/7 complaining of shortness of breath and nausea and vomiting  with elevated troponin and NSTEMI. Low suspicion that the vaccine caused this man?s heart attack as his hear cath showed severe multi-vessel disease. Pt gave inconsistent history in previous COVID infection: he told some he did have it and others that he did not .    CT surgery was consulted, and patient was not felt to have viable targets for CABG.  Cardiology discussed risks and benefits of an attempt at a high risk PCI to the LAD, and patient and family opted for medical management. Patiet discharge home on 4/10/21 with medical management for his coronary artery disease and new onset systolic heart failure with an ejection fraction of 15%, including aspirin, clopidogrel, atorvastatin, Coreg, furosemide, Entresto.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Extra dose administered
Clinical narrative: On 4/6/2021 I went to receive my second COVID-19 (Pfizer) vaccine in the series. I was given 2 vaccines on that date, one right after the other. At about 6 pm on the evening of 4/8/2021, I began to have difficulty swallowing, eventually unable to swallow saliva by around 6:45pm. I was able to force liquid down. My throat remained tight/swollen? so I took 1/2 of a Benadryl at about 8:45. Improvement noted by 9:30 pm. I looked up this symptom and it was noted to be "throat closure sensation".
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphagia, Pharyngeal swelling, Throat tightness
Clinical narrative: On 4/6/2021 I went to receive my second COVID-19 (Pfizer) vaccine in the series. I was given 2 vaccines on that date, one right after the other. At about 6 pm on the evening of 4/8/2021, I began to have difficulty swallowing, eventually unable to swallow saliva by around 6:45pm. I was able to force liquid down. My throat remained tight/swollen? so I took 1/2 of a Benadryl at about 8:45. Improvement noted by 9:30 pm. I looked up this symptom and it was noted to be "throat closure sensation".
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Discomfort, Overdose, Pain in extremity, Pyrexia
Clinical narrative: On 4/6/2021 I went to receive my second COVID-19 (Pfizer) vaccine in the series. I was given 2 vaccines on that date, one right after the other. At about 6 pm on the evening of 4/8/2021, I began to have difficulty swallowing, eventually unable to swallow saliva by around 6:45pm. I was able to force liquid down. My throat remained tight/swollen? so I took 1/2 of a Benadryl at about 8:45. Improvement noted by 9:30 pm. I looked up this symptom and it was noted to be "throat closure sensation".
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site joint movement impairment
Clinical narrative: On 4/6/2021 I went to receive my second COVID-19 (Pfizer) vaccine in the series. I was given 2 vaccines on that date, one right after the other. At about 6 pm on the evening of 4/8/2021, I began to have difficulty swallowing, eventually unable to swallow saliva by around 6:45pm. I was able to force liquid down. My throat remained tight/swollen? so I took 1/2 of a Benadryl at about 8:45. Improvement noted by 9:30 pm. I looked up this symptom and it was noted to be "throat closure sensation".
Sex: U
Vaccine: MMRV, MMRV
Symptoms: Product storage error
Clinical narrative: no additional AE reported/no additional information; temperature excursion with insufficient data ot evaluate/worst case scenario temperature 22C/PROQUAD were administered; This spontaneous report has been received from a health care professional referring to a patient of unknown age and gender. Information regarding pertinent medical history, drug reactions/allergies and concomitant medication was not reported.  On 05-APR-2021, the patient was vaccinated with an improperly stored dose of  Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) recombinant human albumin (rHA) for prophylaxis (lot # T025508, expiration date was reported and validated as 23-JAN-2022; formulation, strength, dose, frequency, and route were not provided) after data logger stopped working. The temperature excursion was detected by a data logger but with insufficient data to evaluate. The worst case scenario data for the excursion was at 22 degree Celsius for 68 hours (Product storage error). There was no previous temperature excursion. No additional adverse event was reported.  This is one of 2 reports received from the same reporter.; Sender's Comments:  US-009507513-2104USA001748:
Sex: U
Vaccine: MMRV, MMRV
Symptoms: Product storage error
Clinical narrative: no additional information; temperature excursion with insufficient data ot evaluate/worst case scenario temperature 22C/PROQUAD were administered; This spontaneous report has been received from a health care professional referring to a patient of unknown age and gender. Information regarding pertinent medical history, drug reactions/allergies and concomitant medication was not reported.  On 05-APR-2021, the patient was vaccinated with an improperly stored dose of  Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) recombinant human albumin (rHA) for prophylaxis (lot # T025508, expiration date was reported and validated as 23-JAN-2022; formulation, strength, dose, frequency, and route were not provided) after data logger stopped working. The temperature excursion was detected by a data logger but with insufficient data to evaluate. The worst case scenario data for the excursion was at 22 degree Celsius for 68 hours (Product storage error). There was no previous temperature excursion. No additional adverse event was reported.  This is one of 2 reports received from the same reporter.; Sender's Comments:  US-009507513-2104USA001744:
Sex: U
Vaccine: MMRV, MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: no additional information; temperature excursion with insufficient data ot evaluate/worst case scenario temperature 22C/PROQUAD were administered; This spontaneous report has been received from a health care professional referring to a patient of unknown age and gender. Information regarding pertinent medical history, drug reactions/allergies and concomitant medication was not reported.  On 05-APR-2021, the patient was vaccinated with an improperly stored dose of  Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) recombinant human albumin (rHA) for prophylaxis (lot # T025508, expiration date was reported and validated as 23-JAN-2022; formulation, strength, dose, frequency, and route were not provided) after data logger stopped working. The temperature excursion was detected by a data logger but with insufficient data to evaluate. The worst case scenario data for the excursion was at 22 degree Celsius for 68 hours (Product storage error). There was no previous temperature excursion. No additional adverse event was reported.  This is one of 2 reports received from the same reporter.; Sender's Comments:  US-009507513-2104USA001744:
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Nervousness
Clinical narrative: Patient experenced  other reduced mobility . Onsite EMS was called vitals BP 150/90 99% O2 HR 90. Patient refused evaluation or care, released against medical advise.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Heart rate, Mobility decreased, Oxygen saturation, Vital signs measurement
Clinical narrative: Patient experenced  other reduced mobility . Onsite EMS was called vitals BP 150/90 99% O2 HR 90. Patient refused evaluation or care, released against medical advise.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood albumin normal, Blood alkaline phosphatase decreased, Blood bilirubin normal
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood calcium normal, Blood chloride increased, Blood creatinine normal, Blood glucose normal, Blood urea decreased
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide normal, Full blood count, Haematocrit normal, Haemoglobin normal, Human chorionic gonadotropin negative
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Petechiae, Platelet count decreased
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Protein total normal, Rash erythematous, Red blood cell count normal, Red cell distribution width normal, Streptococcus test
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombocytopenia, White blood cell count decreased
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immune thrombocytopenia, Laboratory test, Petechiae, Platelet count decreased, Rash
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Transfusion
Clinical narrative: I noticed a petechia rash on my legs the day after I received the first-dose of the Pfizer vaccine on Tuesday, April 06, 2021, I noticed the rash spreading around my chest area, neck area, thighs, and arms as the following days progressed. On Friday, April 09, 2021, I made an appointment at the Student Health Center where I was seen by clinician,  who requested I get blood labs done. After results showed that my platelet count was 30,000, she immediately referred me to the ER at Hospital. She informed that it was an adverse side effect to my first dose of the Pfizer vaccine, she also informed me that it was a very rare instance and there are cases of other individuals that this has also happened to. Dr. informed me my situation was extremely dangerous and could have potentially been fatal if I had not decided to seek medical attention. I was admitted into the  Hospital on April 09, and was discharged on Monday, April 12, 2021. While I was in the hospital, that Friday 04/09 I received a blood transfusion for my low platelet count, it did not show much improvement, I was diagnosed with ITP by clinician  who is a clinician within the Hematology and Oncology department.  Dr. also informed me that this seemed to be an adverse side effect to the first-dose of the Pfizer vaccine, Dr.then recommended I receive steroids for 4 consecutive days to increase my platelet count. The date of my discharge 04/12, my platelet count was 20,000 which is still considered extremely low but due to steroids that were given to me for 4 days, Dr.agreed that this would hopefully increase my platelet count.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: On April 2, 2021 around 8:00 p.m. I begin having chills, body aches, fever ,nausea, etc. This continued until Monday  April 5, 2021, minus the chills. My urine became very dark brown for a few days, then changed to a light pink color.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Chills, Chromaturia
Clinical narrative: On April 2, 2021 around 8:00 p.m. I begin having chills, body aches, fever ,nausea, etc. This continued until Monday  April 5, 2021, minus the chills. My urine became very dark brown for a few days, then changed to a light pink color.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Hepatic function abnormal, Metabolic function test, Nausea, Pain
Clinical narrative: On April 2, 2021 around 8:00 p.m. I begin having chills, body aches, fever ,nausea, etc. This continued until Monday  April 5, 2021, minus the chills. My urine became very dark brown for a few days, then changed to a light pink color.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: On April 2, 2021 around 8:00 p.m. I begin having chills, body aches, fever ,nausea, etc. This continued until Monday  April 5, 2021, minus the chills. My urine became very dark brown for a few days, then changed to a light pink color.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Erythema, Flushing, Sensation of foreign body, Vital signs measurement
Clinical narrative: - 1-2 minutes after the moderna vaccine on 4/10, felt a shock in her head and then her eyes went blurry. Face felt hot. Then it came down to her throat and she felt like there was something big stuck in her throat. It was hard to talk. Husband was there also and noted that Pt had trouble speaking. Felt faint but did not faint. The thing that was stuck in her throat came down to her chest and felt chest tightness. Then a few minutes later, that sensation went away. Ears felt hot and red.         - Pt was monitored following vaccination and BP was taken and was 140s (higher than normal).         - Pt then decided to go to the ED and be monitored. ED provider thought reaction was due to anxiety as symptoms were not classic for an allergic reaction/anaphylaxis and Pt improved without intervention/symptoms resolved. Pt denies anxiety and feels reaction was an AE.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Apraxia, Chest discomfort, Dizziness, Feeling hot, Gastrooesophageal reflux disease
Clinical narrative: - 1-2 minutes after the moderna vaccine on 4/10, felt a shock in her head and then her eyes went blurry. Face felt hot. Then it came down to her throat and she felt like there was something big stuck in her throat. It was hard to talk. Husband was there also and noted that Pt had trouble speaking. Felt faint but did not faint. The thing that was stuck in her throat came down to her chest and felt chest tightness. Then a few minutes later, that sensation went away. Ears felt hot and red.         - Pt was monitored following vaccination and BP was taken and was 140s (higher than normal).         - Pt then decided to go to the ED and be monitored. ED provider thought reaction was due to anxiety as symptoms were not classic for an allergic reaction/anaphylaxis and Pt improved without intervention/symptoms resolved. Pt denies anxiety and feels reaction was an AE.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Vision blurred
Clinical narrative: - 1-2 minutes after the moderna vaccine on 4/10, felt a shock in her head and then her eyes went blurry. Face felt hot. Then it came down to her throat and she felt like there was something big stuck in her throat. It was hard to talk. Husband was there also and noted that Pt had trouble speaking. Felt faint but did not faint. The thing that was stuck in her throat came down to her chest and felt chest tightness. Then a few minutes later, that sensation went away. Ears felt hot and red.         - Pt was monitored following vaccination and BP was taken and was 140s (higher than normal).         - Pt then decided to go to the ED and be monitored. ED provider thought reaction was due to anxiety as symptoms were not classic for an allergic reaction/anaphylaxis and Pt improved without intervention/symptoms resolved. Pt denies anxiety and feels reaction was an AE.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest pain, Pain in extremity, Pleural effusion, Scan
Clinical narrative: Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; high BP; fluid around heart; elevated D DIM; This is a spontaneous report from a contactable consumer (patient).  A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (brand: Pfizer BioNTech, lot: EN6199) in left arm on 06Apr2021 06:30 PM at a single dose for COVID-19 immunization. Facility type vaccine was Pharmacy or Drug Store. Medical history was not reported. Patient was not pregnant (AS REPORTED) at the time of vaccination. Concomitant medications were unspecified. No other vaccine in four weeks. Other medications in two weeks was yes. Patient used to receive Wellbutrin and experienced allergies. Historical vaccine included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: ER8733) in left arm on 17Mar2021 05:00 PM at a single dose for COVID-19 immunization. Patient experienced severe left chest back and shoulder pain lasting more than 2 days accompanied by high blood pressure (BP), fluid around heart and elevated D DIM on 07Apr2021 05:30 AM. Adverse events (AE) resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). The outcome of the events was recovering. AE treatment: Ultrasound, CT Scan, morphine. If COVID prior vaccination was no. If COVID tested post vaccination was no.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Blood pressure measurement, Chest pain, Computerised tomogram
Clinical narrative: Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; high BP; fluid around heart; elevated D DIM; This is a spontaneous report from a contactable consumer (patient).  A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (brand: Pfizer BioNTech, lot: EN6199) in left arm on 06Apr2021 06:30 PM at a single dose for COVID-19 immunization. Facility type vaccine was Pharmacy or Drug Store. Medical history was not reported. Patient was not pregnant (AS REPORTED) at the time of vaccination. Concomitant medications were unspecified. No other vaccine in four weeks. Other medications in two weeks was yes. Patient used to receive Wellbutrin and experienced allergies. Historical vaccine included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: ER8733) in left arm on 17Mar2021 05:00 PM at a single dose for COVID-19 immunization. Patient experienced severe left chest back and shoulder pain lasting more than 2 days accompanied by high blood pressure (BP), fluid around heart and elevated D DIM on 07Apr2021 05:30 AM. Adverse events (AE) resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). The outcome of the events was recovering. AE treatment: Ultrasound, CT Scan, morphine. If COVID prior vaccination was no. If COVID tested post vaccination was no.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Fibrin D dimer increased, Hypertension, Pericardial effusion, Ultrasound scan
Clinical narrative: Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; Severe left chest back and shoulder pain lasting more than 2 days; high BP; fluid around heart; elevated D DIM; This is a spontaneous report from a contactable consumer (patient).  A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (brand: Pfizer BioNTech, lot: EN6199) in left arm on 06Apr2021 06:30 PM at a single dose for COVID-19 immunization. Facility type vaccine was Pharmacy or Drug Store. Medical history was not reported. Patient was not pregnant (AS REPORTED) at the time of vaccination. Concomitant medications were unspecified. No other vaccine in four weeks. Other medications in two weeks was yes. Patient used to receive Wellbutrin and experienced allergies. Historical vaccine included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: ER8733) in left arm on 17Mar2021 05:00 PM at a single dose for COVID-19 immunization. Patient experienced severe left chest back and shoulder pain lasting more than 2 days accompanied by high blood pressure (BP), fluid around heart and elevated D DIM on 07Apr2021 05:30 AM. Adverse events (AE) resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). The outcome of the events was recovering. AE treatment: Ultrasound, CT Scan, morphine. If COVID prior vaccination was no. If COVID tested post vaccination was no.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Lymphadenopathy, Pain in extremity, Rash pruritic
Clinical narrative: Two days after her injection (on 4/11/21) patient developed urticaria on inner thighs. Areas of urticaria progressed to bruising (not petechia) over the next few days. No respiratory symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine normal, Contusion, Full blood count normal, Liver function test normal, Metabolic function test normal
Clinical narrative: Two days after her injection (on 4/11/21) patient developed urticaria on inner thighs. Areas of urticaria progressed to bruising (not petechia) over the next few days. No respiratory symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Two days after her injection (on 4/11/21) patient developed urticaria on inner thighs. Areas of urticaria progressed to bruising (not petechia) over the next few days. No respiratory symptoms.